A Study of Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer

by lowes1 on September 23, 2013

Condition:   Non Small Cell Lung Cancer
Intervention:   Drug: Demcizumab
Sponsors:   OncoMed Pharmaceuticals, Inc.;   OncoMed Pharmaceuticals, Inc.;   Novotech (Australia) Pty Ltd
Recruiting – verified September 2013

View full post on ClinicalTrials.gov: “Lung Neoplasms” | updated in the last 30 days

Leave a Comment

Previous post:

Next post: